These morphological characteristics may suggest that the CD11b+Ly6G+ cells in the Sunitinib group are anti-tumor N1 neutrophils while they remain pro-tumor N2 neutrophils or immunosuppressive G-MDSC in the absence of Sunitinib. This evidence concerns the gene ITGAM and neoplasm.